Tracking Cathie Wood: Added over 70,000 shares of GeneDx, a leader in genetic diagnostics, while trimming positions in Palantir and ATAI to rebalance the portfolio

On Tuesday (August 4), all three major U.S. stock indices staged a strong rebound. The S&P 500 rose 1.79% to close at 7,736.52, the Nasdaq surged 2.59% to 26,584.99, and the Dow Jones climbed 1.71% to 54,085.88, reflecting a significant recovery in market risk appetite, with technology and growth sectors leading the rally.

Amid broad market gains, Cathie Wood actively increased exposure on Tuesday to core disruptive innovation themes such as precision medicine and autonomous driving, while systematically rebalancing certain positions to optimize portfolio structure.

Buying activity: Dual focus on precision medicine and autonomous driving, with additional exposure to streaming platforms

$GeneDx Holdings (WGS.US)$ Received an increase of 73,368 shares, the largest single-day purchase. GeneDx specializes in clinical diagnostics using whole-exome and whole-genome sequencing, and its differentiated capabilities in precise diagnosis of rare diseases closely align with ARK’s long-term bullish thesis on 'precision medicine disrupting traditional diagnostics.' This significant addition likely reflects ARK’s optimistic outlook on the acceleration of its commercialization progress.

$Pony AI (PONY.US)$ Received an increase of 5,500 shares. Pony.ai, a leading player in autonomous driving, continues to advance the commercial rollout of its Robotaxi services, consistent with ARK’s core investment thesis in embodied intelligence and autonomous driving. This purchase likely reflects ARK’s continued confidence in the medium- to long-term commercial prospects of this sector.

$Spotify Technology (SPOT.US)$ Received an increase of 5,128 shares. Spotify continues to solidify its dominant position in the global music and podcast streaming market, with its AI-powered personalized recommendation algorithms deepening its user engagement moat. ARK’s purchase may reflect its positive view on Spotify’s improving monetization efficiency driven by AI.

Selling side: Rebalancing positions across multiple holdings to reduce portfolio concentration

$AtaiBeckley (ATAI.US)$ Reduced by 275,338 shares, the largest single-day sale. As a biotech company focused on mental health, ATAI’s pipeline progress and clinical uncertainties may have prompted ARK to reassess its position size. This substantial reduction likely represents a tactical risk management move and portfolio optimization.

$Palantir (PLTR.US)$ Reduced by 39,233 shares. Given Palantir’s recent strong stock performance, this sale likely constitutes a standard rebalancing action to prevent overexposure to a single holding and to free up capital for reallocation to other opportunities.

KOMATSU LTD. (6301.US) reduced by 27,621 shares. As a traditional heavy machinery giant, Komatsu operates in an industrial segment that diverges somewhat from ARK’s disruptive innovation investment focus. The sale likely reflects ARK’s ongoing effort to refine its portfolio toward high-growth innovative assets.

$10x Genomics (TXG.US)$ Reduced by 24,454 shares. 10x Genomics holds leading technology in single-cell sequencing, but its commercialization progress and near-term profitability remain under market scrutiny. This reduction likely represents a structural adjustment within ARK’s genomics sector holdings.

$Brera Holdings (SLMT.US)$ Reduced by 4,921 shares,$Strata Critical Medical (SRTA.US)$ Reduced by 4,397 shares. Given their relatively small positions, these sales likely represent routine minor position adjustments and liquidity management.

$Natera (NTRA.US)$ 3,189 shares were sold. Natera holds a competitive advantage in the fields of liquid biopsy and non-invasive prenatal testing; this minor reduction is likely a dynamic portfolio adjustment within the precision medicine segment and does not reflect a negative view on fundamentals.

$Roku Inc (ROKU.US)$ 393 shares were sold—a very small amount, representing a symbolic routine position adjustment.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

149K Views